CTLA4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky SCID

CTLA4-Ig controls immune dysregulation in an Artemis deficient mouse model that recapitulates leaky SCID/ Omenn Syndrome clinical manifestations.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2kfm74g
via IFTTT